The purpose of this study was to evaluate the utility of transthoracic echocardiography (TTE) 
Patients admitted to tertiary care medical and surgical intensive care units frequently have cardiovascular dysfunction and are often unable to give detailed medical histories. This can result in difficulty in making correct diagnoses and deciding upon appropriate management. Since its introduction in the late 1970s, transthoracic echocardiography (TTE) has become readily available. Its noninvasive nature and bedside application have made it well suited to aiding diagnosis and informing management of the critically ill patient. While several authors have reported the usefulness of transoesophageal echocardiography (TOE) in the critical care setting [1] [2] [3] [4] [5] [6] [7] [8] [9] and its superiority to TTE as a diagnostic tool in the critical care setting 5, 6 , it is an invasive procedure with attendant risks and complications, and is often not as readily available as TEE.
Although TTE is non-invasive, it remains an expensive modality 7 , and therefore attention has been focused on the appropriate clinical application and utility of TTE 10 . Practice guidelines for the use of echocardiography that have been developed by the American College of Cardiology (ACC) and the American Heart Association (AHA) have been based largely on the consensus of experts 11 . Many studies have shown that echocardiography can aid in the diagnosis of many diverse cardiac abnormalities 12, 13 ; however, until recently few have specifically examined the effect of echocardiography on clinical decisionmaking. Foster and colleagues described the role of TOE in 69 critical care patients 1 . Findings were unexpected in 25% of studies and led to a change in management in 17% of cases. Other studies that have examined the effect of echocardiography on patient care have enrolled cardiology outpatients, hospital ward inpatients, and patients in coronary care units 7, 8, 14 . These studies have demonstrated that the use of echocardiography results in a new diagnosis and/or a change in management in a significant number of patients. Despite the increasing use of echocardiography in the ICU setting, there are few studies that specifically examine the utility of TTE in critically ill patients.
The purpose of this study was to prospectively evaluate the use of TTE in tertiary care ICU patients to determine its impact on diagnosis and management.
METHODS
We obtained approval from University of Manitoba's Ethics Committee to perform this prospective, observational study. Patient consent was not required.
Over a six-month period, all patients admitted to the surgical or medical ICU at the Winnipeg Health Sciences Center who had a request for a TTE while in the intensive care unit (ICU) were eligible for enrolment. Structured interviews using a detailed, standardized questionnaire were conducted with the referring physician before each TTE study. The questionnaire included indications for the TTE, patient characteristics, clinical history, physical findings, results of diagnostic tests including cardiac enzymes, ECG and previous TTE, and current diagnosis and treatment plan. Physicians were asked whether or not they could formulate a management plan based on the clinical data prior to the TTE being performed. Since the impact of TTE on diagnosis and management could be affected by the clinical acumen of the referring physicians, they were required to complete a questionnaire on each patient, stating their clinical findings/diagnosis. This was then compared to the subsequent TTE findings.
Based on the indications for echocardiography for which there is level I evidence, that is, situations for which there is evidence or general agreement that a TTE exam is useful 11 , indications for the TTE were divided as follows: (1) haemodynamic compromise: new shock state, congestive heart failure, complicated myocardial infarction, large pericardial effusion, cardiac tamponade; (2) unexplained hypoxaemia: pulmonary hypertension or cardiac shunting; (3) sepsis syndromes: to evaluate cardiac function in sepsis, or to rule out subacute bacterial endocarditis; (4) trauma: suspected cardiac contusion or evaluation of cardiac function in potential cardiac donors; (5) miscellaneous/other: all other indications for a TTE.
The TTE examination was performed by one of four experienced cardiac sonographers. Standard 2-dimensional parasternal long-and short-axis, apical 4-and 2-chamber, and subcostal 4-chamber views were used. Additional modalities included M-mode, Doppler colour flow mapping, and pulsed-and continuous-wave Doppler. All examinations were performed with a Hewlett Packard Sonos 1000 system (Andover, MA) and were recorded on half-inch VHS videotape for subsequent review and analysis. Echocardiograms were interpreted by one of two boardcertified cardiologists with American Society of Echocardiography level III training. The only information provided to the cardiologists was the indication for the TTE; they were therefore blinded to other clinical and laboratory findings. After the cardiologist interpreted the TTE examination, the results were immediately provided to the ICU physicians in written form. The principal investigator conducted a follow-up standardized questionnaire with the ICU physicians within 24 hours of the TTE report being provided. This included questions to determine whether or not the TTE caused a change in the diagnosis, management, or both.
A diagnostic change based on the TTE was defined to have occurred when the ICU physician reported the exclusion of the initial primary clinical diagnosis, or the inclusion of an additional diagnosis. Management changes based on the TTE were arbitrarily defined as minor or major. Minor management changes included addition of a new medication, discontinuation of a medication, change in drug dosage or anticipated duration of treatment, addition of fluids, initiation or discontinuation of investigations, or initiation of a consult or treatment. Major changes included initiation of a surgical treatment, or discontinuation of active treatment in favour of palliative care.
As a test of clinical acumen, predictors for the following cardiac disease states were made by each of the physician groups (Attending intensivists, ICU fellows, and ICU residents): moderate mitral regurgitation, moderate aortic stenosis, moderate-sized pericardial effusion, presence/absence regional wall motion abnormalities (ischaemia/infarction), and estimate of left ventricular ejection fraction.
The frequency of events between groups was compared using Chi-square analysis. Pre-specified subgroup analyses included comparing the frequency of diagnostic and management changes for age, gender, study indications, presence of antecedent cardiac history, and absence/presence of adequate clinical data.
RESULTS
There were 633 patients admitted to the intensive care units over the study period, and 126 of these patients (126/633; 19.9%) had at least one TTE examination (Table 1) . Of the 135 requisitions for a TTE, 26 (19.3%) were made by the attending intensivist, 50 (37%) by the ICU fellow, and 59 (43.7%) by the ICU resident. The primary indications for performing the TTE are shown in Table 2 . The interpreting cardiologists gave a diagnostic report on all of the 135 studies, although in 13 studies, the report included a statement that the examination was suboptimal. The TTE was abnormal in 121/135 studies. The mean LVEF was 52%±17%. In 57 (42%) studies there were regional wall motion abnormalities. Even though physicians indicated that they had sufficient data by history, physical findings, laboratory and ancillary tests (electrocardiogram, chest X-ray, and others) to formulate a diagnosis and management plan in the majority of patients (99/135; 73%), TTE was frequently ordered as a corroborative test and management tool (Table 3 ). The TTE resulted in a changed diagnosis in 39/135 (29%) of studies (either a change in the primary diagnosis or inclusion of an additional diagnosis). A change in diagnosis occurred more often in the inadequate clinical data group than the adequate clinical data group. The TTE resulted in a change in management in 55/135 (41%) of studies. Similarly, a change in the management plan occurred more often in the inadequate clinical data group than the adequate clinical data group. The types of management changes are shown in Table 4 . Management changes that occurred as a result of new information obtained from the TTE were determined to be either minor or major by predetermined criteria. A total of 62 management changes occurred in 55 patients, with the majority being minor changes. The addition of a medication was the most common consequence, followed by discontinuation of a medication, initiation of an investigation, and initiation of a consult. A smaller number of patients had major changes in management such as a new surgical procedure or discrimination of active treatment. In a univariate analysis, the frequency of overall diagnostic and management changes were independent of gender, age, clinical indications, prior cardiac history, or availability of previous echo reports.
The various groups of ICU physicians were generally good at predicting cardiac abnormalities (Table 5) . 
DISCUSSION
The results of this study suggests that selective use of TTE in tertiary care critical care units can lead to frequent changes in the diagnosis (29%) and management (41%) of critically ill patients. While the frequency of such changes was more common in patients in whom the clinicians felt that the clinical information was inadequate, a large number of patients had diagnostic and management changes even though the clinicians felt that there was adequate clinical information. The referring physicians performed well on a questionnaire comparing their clinical assessment to the TTE, suggesting that the frequent changes in diagnosis and management were not due to poor clinical acumen of the referring physicians.
Although the utility of TTE is not as well documented in the literature as TOE it may have the advantage because it is non-invasive and does not require physician expertise while the examination is being performed. Although our study only specifically addresses the utility of TTE in patients at a medical and surgical ICU in a tertiary medical centre, there are several other studies that have addressed the utility of TTE in other patient populations. Tam et al reported that the frequency of management changes in hospitalized patients resulted from the results of the TTE were more common in the critically ill patients than in non-critically ill patients (ICU 29/53 vs non-ICU 158/428, P=0.02) 15 . In an earlier study, Krumholz and co-workers examined the utility of TTE in the care of inpatients and outpatients at a large community-based teaching hospital 8 . These authors reported that the TTE commonly provided information that was unexpected and produced a definitive, new diagnosis in 10% (25/244) of inpatients and in 5% (5/101) of outpatients, but the specific impact on the management of these patients was not provided. Waggoner and colleagues investigated the effect of echocardiography on the diagnosis and management of patients in a cardiology outpatient clinic setting 14 . A new diagnosis was made in 8.5% (17/200) of patients, and echocardiography resulted in a change in management in 36% (73/200) patients. Similarly, in acute coronary syndromes, Kim and colleagues showed that the echocardiogram provided new information that altered the diagnosis and/or management in 29% of patients 7 . A common important finding in all of these studies was that TTE often led to a change in the patient's diagnosis and/or management, even when competent clinicians felt that they had enough information to diagnose and manage the patient.
There are several limitations to our study. The first limitation of this study was that we examined the utility of TTE in patients in whom the referring physicians had already requested the test. This population consisted of 126/633 (20%) of all patients admitted to the medical and surgical ICU. The proportion of total ICU patients receiving an echocardiogram in the eight months prior to our study was identical (170/838, 20%). In our study, the decision to obtain an echocardiogram was made by the referring physician after examining the available clinical information. However, limitations of resources in the Canadian medical system may have affected the number of TTE studies requested, and may therefore under-represent the number of TTE studies done in a medical system where high-tech resources are more readily available. This would potentially decrease the absolute utility of the test.
Another limitation of the study is the observational, non-randomized nature of the study. It was impossible to determine whether some or all of the management changes would have occurred with time even without echocardiography. The TTE may simply have led to earlier diagnoses and possibly earlier treatment. For instance, in the evaluation of left ventricular function, the TTE results may have allowed for earlier institution of appropriate medical therapy, which might otherwise have been instituted anyway in time should overt heart failure have developed. On the other hand, clinicians may deliberately delay the institution of a new therapy based on clinical findings knowing that TTE confirmation of their diagnosis is pending. This practice may reflect varying levels of confidence that clinicians have in their diagnostic skills, and their threshold for obtaining more confirmatory information before formulating a definitive diagnosis and management plan, and may explain the high frequency of management changes that occurred in our study. In addition, medicolegal concerns may also significantly impact on clinicians. Hard data in the form of a TTE report may influence their management more than clinical findings alone. The third limitation of our study is the inability to comment on whether TTE actually affects outcome in ICU patients. There are many confounding variables that affect the outcome in ICU patients and it would be difficult to design a randomized study examining the utility of TTE in ICU. However, an attempt at evaluating pulmonary artery catheters in ICU has recently been published 16 , suggesting that attempts at assessing ICU technology is possible.
The final limitation of this study is that the TTE examinations that were performed in this studied, used, relatively old technology, in the form of Hewlett Packard Sonos 1000 system. However during these examinations full use was made of the M-mode, Doppler colour flow mapping, and pulsed-and continuous-wave Doppler as required. It is unlikely that the more sophisticated, newer TEE technology would have substantially changed the results of this study. Newer technology will certainly improve image quality and may even lead to an increase in detection of subtle cardiac abnormalities, which would potentially increase the rate of diagnosis and medical management changes. The major findings detected on TEE in which clinical decision-making is based on has not been made obsolete by the newer technologies.
In conclusion, rational use of TTE in tertiary care medical and surgical intensive care units frequently led to a change in the diagnosis and management of patients, regardless whether clinical information was felt to be adequate or inadequate. The results of this study support the more widespread use of TTE in critically ill patients.
